Abiraterone – July 2021

• Brand names:
  • Zytiga®
• Pharmaceutical Company:
  • Janssen-Cilag Pty Ltd
• Condition/Indication: Castration resistant carcinoma of the prostate
• Meeting Date: July 2021
• Public Summary Document (PSD) July 2021 PBAC Meeting
• Public Summary Document (PSD) July 2021 PBAC Meeting - (Word)

Related Public Summary Documents

• Enzalutamide – July 2021